The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice

被引:29
|
作者
Burns, Ted M. [1 ]
机构
[1] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA
来源
关键词
MG composite; myasthenia gravis; outcome measures; MGC; MG; MYCOPHENOLATE-MOFETIL; RECOMMENDATIONS; CYCLOSPORINE; RELIABILITY; VALIDATION; STANDARDS; IVIG;
D O I
10.1111/j.1749-6632.2012.06812.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The myasthenia gravis composite (MGC) was constructed by selecting the best performing items from three commonly used, MG-specific scales. The response categories of the items were subsequently weighted for importance. The MGC, which takes less than five minutes to complete, is made up of three ocular, three bulbar, one respiratory, one neck, and two limb items. After its construction, the MGC was validated in an 11-center scale validity study. During the validation study, which included test-retest analysis, it was determined that a 3-point improvement in MGC score reliably indicates clinical improvement. A 3-point improvement in MGC also appears to be meaningful to the patient. Rasch analysis of the MGC confirmed that all 10 items belong and can be summed to provide a total score, and that the weights given to the response categories of the items are appropriate.
引用
收藏
页码:99 / 106
页数:8
相关论文
共 50 条
  • [31] Clinical outcome after thymectomy in Thai myasthenia gravis patients
    Dejthevaporn, C
    Thukkinstian, A
    Sirisinha, T
    Witoonpanich, R
    Kaewkungwa, J
    Singhasivanon, P
    Sirinavin, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S173 - S173
  • [32] Clinical outcome of generalized myasthenia gravis in Hong Kong Chinese
    Lee, C. Y.
    Lam, C. L.
    Pang, S. Y. Y.
    Lau, K. K.
    Teo, K. C.
    Chang, R. S. K.
    Chan, K. H.
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 289 : 177 - 181
  • [33] Clinical features and outcome of acquired myasthenia gravis in 94 dogs
    Forgash, Jennifer T.
    Chang, Yu-Mei
    Mittelman, Neil S.
    Petesch, Scott
    Benedicenti, Leontine
    Galban, Evelyn
    Hammond, James J.
    Glass, Eric N.
    Barker, Jessica R.
    Shelton, G. Diane
    Luo, Jie
    Garden, Oliver A.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2021, 35 (05) : 2315 - 2326
  • [34] Clinical observations on the use of prostigmin in the treatment of myasthenia gravis
    Laurent, LPE
    BRITISH MEDICAL JOURNAL, 1935, 1935 : 463 - 465
  • [35] Correlation Between Thymus Radiology and Myasthenia Gravis in Clinical Practice
    Luo, Huan
    Xie, Shanshan
    Ma, Chao
    Zhang, Wenqiang
    Tschoepe, Carsten
    Fa, Xianen
    Cheng, Jingliang
    Cao, Jing
    FRONTIERS IN NEUROLOGY, 2019, 9
  • [36] Rituximab for the treatment of generalised myasthenia gravis: experience in clinical practice
    Martinez-Monte, Elena
    Gascon-Gimenez, Francisco
    Dominguez-Moran, Jose Andres
    Lainez-Andres, Jose Miguel
    REVISTA DE NEUROLOGIA, 2021, 73 (12) : 416 - 420
  • [37] The Use of MR Imaging as an Outcome Measure in Multiple Sclerosis Clinical Trials
    Bermel, Robert A.
    Fisher, Elizabeth
    Cohen, Jeffrey A.
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2008, 18 (04) : 687 - 701
  • [38] VATS Thymectomy for Nonthymomatous Myasthenia Gravis Standardized Outcome Assessment Using the Myasthenia Gravis Foundation of America Clinical Classification
    Keating, Cameron P.
    Kong, Yu X.
    Tay, Valerie
    Knight, Simon R.
    Clarke, C. Peter
    Wright, Gavin M.
    INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY, 2011, 6 (02) : 104 - 109
  • [39] Utilization of MG-ADL in myasthenia gravis clinical research and care
    Muppidi, Srikanth
    Silvestri, Nicholas J.
    Tan, Robin
    Riggs, Kimberly
    Leighton, Trevor
    Phillips, Glenn A.
    MUSCLE & NERVE, 2022, 65 (06) : 630 - 639
  • [40] The Evolution of Myasthenia Gravis-Activities of Daily Living (MG-ADL) Scale Utilization to Measure Myasthenia Gravis Symptoms and Treatment Response
    Muppidi, Srikanth
    Silvestri, Nicholas
    Tan, Robin
    Riggs, Kimberly
    Leighton, Trevor
    NEUROLOGY, 2021, 96 (15)